Wattanapat Hospital Trang Valuation
Is WPH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of WPH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: WPH-R (THB8.9) is trading above our estimate of fair value (THB1.77)
Significantly Below Fair Value: WPH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for WPH-R?
Other financial metrics that can be useful for relative valuation.
What is WPH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿5.99b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.9x |
Enterprise Value/EBITDA | 27x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does WPH-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 21.1x | ||
NTV Nonthavej Hospital | 14.6x | n/a | ฿5.7b |
EKH Ekachai Medical Care | 18.3x | 4.5% | ฿5.4b |
TNH Thai Nakarin Hospital | 14.8x | n/a | ฿6.3b |
CMR Chiang Mai Ram Medical Business | 36.6x | n/a | ฿8.0b |
WPH-R Wattanapat Hospital Trang | 64.5x | n/a | ฿6.0b |
Price-To-Earnings vs Peers: WPH-R is expensive based on its Price-To-Earnings Ratio (64.5x) compared to the peer average (21.3x).
Price to Earnings Ratio vs Industry
How does WPH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: WPH-R is expensive based on its Price-To-Earnings Ratio (64.5x) compared to the TH Healthcare industry average (26.8x).
Price to Earnings Ratio vs Fair Ratio
What is WPH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 64.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate WPH-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.